Literature DB >> 7901801

Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture.

T Alexi1, F Hefti.   

Abstract

Transforming growth factor alpha messenger RNA and protein levels are highest in the striatum, the target area of mesencephalic dopaminergic neurons of the substantia nigra, suggesting a role as a target-derived neurotrophic factor for these cells. To test this hypothesis, we characterized the actions of transforming growth factor alpha on fetal rat dopaminergic neurons in culture. Transforming growth factor alpha promoted dopamine uptake in a dose- and time-dependent manner. Administration of transforming growth factor alpha at the time of plating for 2 h produced a significant increase in dopamine uptake after five days of growth in vitro. As cultures aged they became less responsive to transforming growth factor alpha, such that longer times of exposure were required to elicit a similar, but weaker, response. Dopaminergic cell survival was selectively promoted by transforming growth factor alpha, since there was an increase in the number of tyrosine hydroxylase-immunostained cells without a parallel increase in the total number of neuron-specific enolase-immunopositive cells. Neurite length, branch number and soma area of tyrosine hydroxylase-immunopositive cells also were enhanced by transforming growth factor alpha treatment. Increases in each of the dopaminergic parameters due to transforming growth factor alpha were accompanied by a rise in glial cell number, making it possible that these effects were mediated by this cell population. The neurotrophin antagonist, K252b, failed to inhibit the transforming growth factor alpha-induced increase in dopamine uptake, indicating that transforming growth factor alpha's effects were not mediated by neurotrophin mechanisms. The actions of transforming growth factor alpha on the differentiation of dopaminergic neurons only partially overlapped with those of epidermal growth factor. Thus, while transforming growth factor alpha and epidermal growth factor are believed to share the same receptor they differentially affect dopaminergic cell development in vitro. These results indicate that transforming growth factor alpha is a trophic factor for mesencephalic cells in culture and suggests that transforming growth factor alpha plays a physiological role in the development of these cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901801     DOI: 10.1016/0306-4522(93)90307-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

2.  Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.

Authors:  S Hunot; V Bernard; B Faucheux; F Boissière; E Leguern; C Brana; P P Gautris; J Guérin; B Bloch; Y Agid; E C Hirsch
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.

Authors:  J Strelau; A Sullivan; M Böttner; P Lingor; E Falkenstein; C Suter-Crazzolara; D Galter; J Jaszai; K Krieglstein; K Unsicker
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

4.  Increased serum levels of epidermal growth factor in children with autism.

Authors:  Elvan Işeri; Esra Güney; Mehmet F Ceylan; Ayşegül Yücel; Arzu Aral; Sahin Bodur; Sahnur Sener
Journal:  J Autism Dev Disord       Date:  2011-02

Review 5.  Growth factors: potential therapeutic applications in neurology.

Authors:  J Drago; T J Kilpatrick; S A Koblar; P S Talman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154

6.  A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor.

Authors:  M Sibilia; J P Steinbach; L Stingl; A Aguzzi; E F Wagner
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

7.  Dopaminergic innervation of striatal grafts placed into different sites of normal striatum: differences in the tyrosine hydroxylase immunoreactive growth pattern.

Authors:  L Björklund; I Strömberg
Journal:  Exp Brain Res       Date:  1997-01       Impact factor: 1.972

8.  Heparin-binding epidermal growth factor-like growth factor in hippocampus: modulation of expression by seizures and anti-excitotoxic action.

Authors:  L A Opanashuk; R J Mark; J Porter; D Damm; M P Mattson; K B Seroogy
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

Review 9.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

10.  Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts.

Authors:  I Strömberg; M Johansson
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.